CLOs on the Move


 
Today`s Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside of the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
  • Number of Employees: 10K-50K
  • Annual Revenue: > $1 Billion
  • www.merck.com
  • 2000 Galloping Hill Road
    Kenilworth, NJ USA 07033
  • Phone: 908.740.4000

Executives

Name Title Contact Details
Andy Custer
Executive Director, Office of General Counsel, Patents Profile
Isabel Duffy
SVP, Chief Ethics and Compliance Officer Profile
Carolyn Kendall
Director, Legal Counsel Profile
Elizabeth Powell
Managing Counsel and Executive Director of Commercial and Compliance Legal Profile
Sue Koch
Associate Director, Legal Operations Technology Profile

Similar Companies

XIL Consulting

PBM consulting, provider nnetwork strategies, rebate benchmarking, global drug sourcing, client pricing, market assessments, MAC management, rebate aggregation.

Beckman Coulter

Beckman Coulter Inc. is a Danaher Corporation company that develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing.

JDS Pharmaceuticals

JDS Pharmaceuticals is a New York, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Tarsus Pharmaceuticals

Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.

Clover Biopharmaceuticals

Founded in 2007, we are a global clinical-stage biotechnology company committed to developing novel vaccines and biologic therapeutic candidates for infectious diseases as well as cancer and autoimmune diseases. Our vision is to empower humanity with a healthier future through transformative science. Our mission is to leverage the Trimer-Tag™ technology platform and manufacturing capabilities for the discovery, development and commercialization of novel vaccines and biologic therapies.